4DMedical (ASX:4DX) said JPMorgan Chase and its affiliates acquired voting power of 5.27% in the firm as of June 19, becoming a substantial holder, according to a Wednesday Australian bourse filing.
JPMorgan Chase now holds 31.4 million ordinary shares of the firm.